India’s First Indigenous Antibiotic ‘Nafithromycin’
On 18th October 2025, Union Minister of State (Independent Charge) for Science and Technology announced that India has developed its first indigenous antibiotic, Nafithromycin, marking a historic milestone in the nation’s pursuit of self-reliance in the pharmaceutical and biotechnology sectors.
- Nafithromycin is the first antibiotic molecule to be conceptualised, developed, and clinically validated entirely in India, showcasing the nation’s growing R&D capability.
- The breakthrough was achieved through a collaboration between the Department of Biotechnology and Wockhardt Ltd, highlighting the power of industry-academia partnerships in scientific ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Sunlight-Powered Self-Charging Energy Storage Device
- 2 Carbon Capture, Utilisation and Storage (CCUS)
- 3 AI@Work
- 4 VoicERA on BHASHINI National Infrastructure
- 5 WHO Prequalifies Novel Oral Polio Vaccine Type 2 (nOPV2)
- 6 Indigenous Td Vaccine Launched
- 7 INCOIS Launches Three Ocean Information Services
- 8 L&T Wins Contract to Build India’s LIGO Observatory in Maharashtra
- 9 Solid Fuel Ducted Ramjet (SFDR) Technology
- 10 Agni-III Missile Test: India Validates Strategic Deterrence Capability

